Results 221 to 230 of about 2,626,240 (311)

Testing methods used to predict disease progression in children with early‐stage type 1 diabetes: A systematic review and meta‐analysis

open access: yesDiabetic Medicine, EarlyView.
Abstract Aims Current guidance on how best to monitor children and young people (CYP) with early‐stage type 1 diabetes is evidenced mainly by expert consensus. This systematic review and meta‐analysis aims to evaluate the current evidence for tests used to predict disease progression. Methods Data were sourced from PubMed, Cochrane Central, Ovid Embase
Rabbi Swaby   +9 more
wiley   +1 more source

Glycated Albumin to Glycated Hemoglobin Ratio is a Sensitive Indicator of Blood Glucose Variability in Patients with Fulminant Type 1 Diabetes

open access: hybrid, 2012
Hiroaki Matsumoto   +8 more
openalex   +2 more sources

The Multi-Center Randomized Controlled Trial (RCT) Published by the Journal of the American Medical Association (JAMA) on the Effect of Periodontal Therapy on Glycated Hemoglobin (HbA1c) Has Fundamental Problems [PDF]

open access: green, 2014
Wenche S. Borgnakke   +20 more
openalex   +1 more source

Long‐term outcomes following alternative second‐line oral glucose‐lowering treatments: Results from the real‐world progression in type 2 diabetes mellitus United Kingdom (RAPIDS‐UK) model

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To compare long‐term complications for people with type 2 diabetes mellitus (T2DM) following second‐line treatment in routine practice with sulphonylureas (SU), dipeptidyl peptidase‐4 inhibitors (DPP4i), or sodium‐glucose co‐transporter‐2 inhibitors (SGLT2i) added to metformin.
Orlagh U. Carroll   +8 more
wiley   +1 more source

Glycated Hemoglobin A1c and Diabetes Complications

open access: bronze, 2012
Abdullah Abdalrahman Almarzouki   +2 more
openalex   +1 more source

Why, how and in whom should we measure levels of lipoprotein(a): A review of the latest evidence and clinical implications

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Lipoprotein(a) [Lp(a)] is a genetically determined, causal risk factor for atherosclerotic cardiovascular disease (ASCVD) and calcific aortic valve disease (CAVD). Despite robust evidence from epidemiological and genetic studies, Lp(a) remains underrecognised in clinical practice due to challenges in measurement, lack of guideline familiarity ...
Alexander C. Razavi   +4 more
wiley   +1 more source

Cost‐effectiveness of ON101 with general wound care for diabetic foot ulcers among patients with type 2 diabetes in Singapore: Analysis of a multi‐ethnic country in Asia

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Diabetic foot ulcers (DFUs) impose a vast health and economic burden on individuals and healthcare systems globally. We assessed the cost‐effectiveness of adding ON101, a novel treatment for accelerating wound healing, to general wound care (GWC) versus GWC alone for DFUs in Singapore, a multi‐ethnic country with increasing DFU prevalence
Hsuan‐Yu Su   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy